Merck contributing to Jacobio Pharma colorectal cancer clinical trial
Jacobio announced it has entered into a clinical trial collaboration agreement with Merck on a…
October 13, 2022 - 2 minutes
Eli Lilly
Study of injection to treat schizophrenia to begin after $3M payment received
A phase 3 clinical trial for an injection to treat patients with schizophrenia has been…
September 1, 2022 - 2 minutes
Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek
This week our guests on the podcast are Xianghao Zuo, deputy director of R&D at…
August 19, 2022 - 3 minutes
Up to 500 new jobs as Lilly invests $2.1B in new manufacturing sites
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…
May 27, 2022 - 3 minutes
Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M
Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…
April 3, 2020 - 2 minutes
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
March 24, 2020 - 3 minutes
Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
September 30, 2019 - 4 minutes
AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
September 23, 2019 - 2 minutes
Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics
In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…
September 6, 2018 - 2 minutes
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
February 23, 2018 - 3 minutes
Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval
Update (13/02/2018): The European Commission has given Novo Nordisk a market authorization for Ozempic (semaglutide), bringing…
February 13, 2018 - 2 minutes
Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines
CureVac will be working with pharma giant Eli Lilly in the development of up to…
October 18, 2017 - 3 minutes
